Follow
Thomas A. Mellan
Thomas A. Mellan
Protocol Labs
Verified email at protocol.ai
Title
Cited by
Cited by
Year
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ...
Nature 584 (7820), 257-261, 2020
2928*2020
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil
NR Faria, TA Mellan, C Whittaker, IM Claro, DS Candido, S Mishra, ...
Science 372 (6544), 815-821, 2021
9122021
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ...
Nature 599 (7883), 114-119, 2021
5252021
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ...
The Lancet Global Health 8 (9), e1132-e1141, 2020
4652020
Evolution and epidemic spread of SARS-CoV-2 in Brazil
DS Candido, IM Claro, JG De Jesus, WM Souza, FRR Moreira, ...
Science 369 (6508), 1255-1260, 2020
4402020
Reduction in mobility and COVID-19 transmission
P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ...
Nature communications 12 (1), 1-9, 2021
2422021
Imperial College COVID-19 Response Team
S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ...
Estimating the effects of non-pharmaceutical interventions on COVID-19 in …, 2020
2252020
Age groups that sustain resurging COVID-19 epidemics in the United States
M Monod, A Blenkinsop, X Xi, D Hebert, S Bershan, S Tietze, M Baguelin, ...
Science 371 (6536), eabe8372, 2021
1682021
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ...
Science 374 (6570), 995-999, 2021
1552021
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study
NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ...
The Lancet Infectious Diseases 20 (12), 1381-1389, 2020
1372020
State-level tracking of COVID-19 in the United States
HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ...
Nature communications 11 (1), 1-9, 2020
1252020
Report 21: Estimating COVID-19 cases and reproduction number in Brazil
TA Mellan, HH Hoeltgebaum, S Mishra, C Whittaker, RP Schnekenberg, ...
1132020
Response to COVID-19 in South Korea and implications for lifting stringent interventions
A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ...
BMC medicine 18 (1), 1-12, 2020
1102020
Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus
NR Faria, TA Mellan, C Whittaker, IM Claro, DDS Candido, S Mishra, ...
Brazil. medRxiv 2021 (26.21252554), 2021
962021
Supplementary data–report 34: COVID-19 infection fatality ratio: estimates from seroprevalence
N Brazeau, R Verity, S Jenks, H Fu, C Whittaker, P Winskill, I Dorigatti, ...
London: Imperial College, 2020
842020
SARS-CoV-2 B. 1.617 emergence and sensitivity to vaccine-elicited antibodies
I Ferreira, R Datir, G Papa, S Kemp, B Meng, P Rakshit, S Singh, ...
BioRxiv, 2021
792021
Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England
S Mishra, S Mindermann, M Sharma, C Whittaker, TA Mellan, T Wilton, ...
EClinicalMedicine 39, 101064, 2021
662021
Density functional theory study of rutile VO2 surfaces
TA Mellan, R Grau-Crespo
The Journal of chemical physics 137 (15), 154706, 2012
642012
Report 19: The potential impact of the COVID-19 epidemic on HIV, TB and malaria in low-and middle-income countries
A Hogan, B Jewell, E Sherrard-Smith, J Vesga, O Watson, C Whittaker, ...
582020
SARS-CoV-2 B. 1.617. 2 Delta variant emergence and vaccine breakthrough
P Mlcochova, S Kemp, MS Dhar, G Papa, B Meng, S Mishra, C Whittaker, ...
Research Square, 2021
572021
The system can't perform the operation now. Try again later.
Articles 1–20